Skip to main content
OpenTrials
Completed

NCT Number: NCT01846195

Evaluation of the Zynex Blood Volume Monitor in Healthy Adult Patients During a Blood Draw

Non-invasive monitoring to measure changes in blood volume.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Blood Loss Hemorrhage Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year–35 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Premier Research Group

Salt Lake City, Utah, 84107, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy volunteers
  • Between 18-35 years of age
  • Weight between 130-200 pounds

Exclusion criteria

  • Known cardiac disease
  • Recent caffeine intake
  • Tobacco use in the (4) hours prior to screening
  • Infection
  • Pregnancy
  • Hemoglobin <13.5 g/dl

Treatment and study plan

CM 1500

Device

Primary outcomes

  1. Detect by Non-invasive Monitoring a Change in Blood Volume During a Whole Blood Draw

    Time frame: At study completion (completion of blood draw)

    Detection by non-invasive monitoring a change in blood volume (yes or no) during a whole blood draw

Sponsors and collaborators

Lead sponsor

Zynex Monitoring Solutions

Industry

Collaborators

  • DTarget

Registry information

Official study title

Clinical Evaluation of the Zynex Blood Volume Monitor (CM-1500) in Healthy Adult Patients During a Blood Draw

Important dates

Study start
2012
Primary completion
2013
Study completion
2013
First posted
May 3, 2013
Registry last updated
Nov 9, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.